Drug Patent Expirations for Sep 22, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

JENTADUETO XR (linagliptin; metformin hydrochloride)
Boehringer Ingelheim
Patent number: 6,340,475
Expiration Date: Sep 19, 2016

JENTADUETO XR (linagliptin; metformin hydrochloride)
Boehringer Ingelheim
Patent number: 6,635,280
Expiration Date: Sep 19, 2016

PROQUIN XR (ciprofloxacin hydrochloride)
Depomed Inc
Patent number: 5,972,389
Expiration Date: Sep 19, 2016

PROQUIN XR (ciprofloxacin hydrochloride)
Depomed Inc
Patent number: 6,340,475
Expiration Date: Sep 19, 2016

PROQUIN XR (ciprofloxacin hydrochloride)
Depomed Inc
Patent number: 6,635,280
Expiration Date: Sep 19, 2016

GRALISE (gabapentin)
Depomed Inc
Patent number: 6,340,475
Expiration Date: Sep 19, 2016

GRALISE (gabapentin)
Depomed Inc
Patent number: 6,635,280
Expiration Date: Sep 19, 2016

GLUMETZA (metformin hydrochloride)
Santarus Inc
Patent number: 6,340,475
Expiration Date: Sep 19, 2016

GLUMETZA (metformin hydrochloride)
Santarus Inc
Patent number: 6,635,280
Expiration Date: Sep 19, 2016

JANUMET XR (metformin hydrochloride; sitagliptin phosphate)
Merck Sharp Dohme
Patent number: 6,340,475
Expiration Date: Sep 19, 2016

JANUMET XR (metformin hydrochloride; sitagliptin phosphate)
Merck Sharp Dohme
Patent number: 6,635,280
Expiration Date: Sep 19, 2016

RETIN-A MICRO (tretinoin)
Valeant Intl
Patent number: 5,955,109
Expiration Date: Sep 21, 2016

RETIN-A-MICRO (tretinoin)
Valeant Intl
Patent number: 5,955,109
Expiration Date: Sep 21, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: